| Identification | Back Directory | [Name]
Ned 19 | [CAS]
874374-25-1 | [Synonyms]
Ned 19
1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid
1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-[3-[[4-(2-fluorophenyl)-1-piperazinyl]methyl]-4-methoxyphenyl]-2,3,4,9-tetrahydro- | [Molecular Formula]
C30H31FN4O3 | [MDL Number]
MFCD02057367 | [MOL File]
874374-25-1.mol | [Molecular Weight]
514.59 |
| Chemical Properties | Back Directory | [Boiling point ]
715.1±60.0 °C(Predicted) | [density ]
1.316±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
2.17±0.40(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
Ned 19 is a selective membrane-permeant non competitive NAADP antagonist and inhibits NAADP-mediated Ca2+ signaling, with an IC50 of 65 nM[1]. Ned 19 strongly inhibits tumor growth and vascularization as well as lung metastases in mice[2]. | [in vivo]
Ned 19 (i.p.; 5?mg/Kg/every second day; 4 week) impaires severely tumor growth[2].
| Animal Model: | Adult male C57BL/6 mice[2] | | Dosage: | 5?mg/Kg | | Administration: | I.p.; every second day; 4 week | | Result: | Impaired severely tumor growth.
|
| [References]
[1] Rosen D, et al. Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonistNed-19 indicate two binding sites on the NAADP receptor. J Biol Chem. 2009 Dec 11;284(50):34930-4. DOI:10.1074/jbc.M109.016519
[2] Annarita Favia, et al. NAADP-Dependent Ca2+ Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis. Sci Rep. 2016; 6: 18925. |
|
| Company Name: |
cjbscvictory
|
| Telephone: |
13348960310 13348960310 |
| Website: |
www.weikeqi-biotech.com/ |
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|